PCA clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • PSMA PET Combined With MRI for the Detection of PCa

    Sorry, in progress, not accepting new patients

    This is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI) compared to standard of care (SOC) for the detection of prostate cancer (PCa).

    San Francisco, California and other locations

Our lead scientists for PCA research studies include .

Last updated: